ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Darifenacin
C28H30N2O2
426.5 g/mol
API

Darifenacin

CAS133099-04-4EC603-704-1
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material

Darifenacin is a pharmaceutical intermediate and active pharmaceutical ingredient used in the manufacturing of medications for overactive bladder. It is a chemical compound with amide and amine functional groups, featuring a complex ring structure that includes aromatic and heterocyclic components.

Pharmaceutical manufacturing intermediateActive pharmaceutical ingredient for overactive bladder medications

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 133099-04-4

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Darifenacin hydrobromide

CAS133099-07-7

pharmaceutical raw material

ReferenceSame Category

Insulin Lispro

CAS133107-64-9

pharmaceutical raw material

ReferenceSame Category

Flutamide

CAS13311-84-7

pharmaceutical raw material

ReferenceSame Category

Apalutamide metabolite M2

CAS1332391-92-0

pharmaceutical raw material

ReferenceSame Category

O-Acetyl Octreotide

CAS133304-81-1

pharmaceutical raw material

Identifiers
IUPAC Name

2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide

InChIKey

HXGBXQDTNZMWGS-RUZDIDTESA-N

SMILES

C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5

Synonyms (21)
  • Darifenacin (USAN/INN)
  • DARIFENACIN [MART.]
  • Darifenacin
  • Darifenacin (hydrobromide)
  • Darifenacin extended release
  • Darifenacina
  • Darifenacinum
  • Emselex
  • UK-88525 (hydrobromide)
  • [3H]darifenacin
  • darifenacine
  • darifenicin